Serial Number:
79402309
Mark:
SEAMLESS
Status:
Non-final action-Mailed
Status Date:
09-07-2024
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Pharmaceutical and biological preparations or active substances for the treatment of diseases; medical, pharmaceutical and biopharmaceutical preparations and substances for the treatment of diseases; pharmaceutical goods and preparations, namely gene transfer, regulation, modulation and delivery medications for the treatment of genetic diseases and disorders; products, agents, for medical purposes, for veterinary purposes; genome editable enzymes; dna recombinant enzymes; dna editable enzymes, especially, recombinases and integrases; genome editable enzymes for the treatment of diseases; dna recombinant enzymes for the treatment of diseases; dna editable enzymes, in particular recombinases and integrases, for the treatment of diseases. Chemicals for use in industry and science; biological preparations, biological reagents, for use in industry and science. Medical services; medical analysis relating to the treatment of persons; assay services, for treatment purposes; medical services and medical services, in relation to the following fields: genome editing; genetic counseling; therapy services; services for the preparation of medical reports; providing personalised healthcare and medical information; providing therapy recommendations; providing of information and counselling services, in relation to the following fields: medical services, health care services; therapy consultancy, in relation to the following fields: genome editing; counselling relating to recombinases and integrases for the treatment of diseases. Medical apparatus and instruments; laboratory apparatus for medical diagnostic purposes. Scientific and technological services and research, especially creation and application of bioinformatic algorithms and models; science and technology services, scientific and technological research, scientific development services, technological development, relating to the following sectors: gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy for the development of pharmaceutical and biological preparations or medications for humans and diagnostic goods and services; consultancy services relating to development of pharmaceutical and biological preparations or medications for humans in the field of gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy; genome engineering services; scientific research relating to genetics, scientific research, relating to the following sectors: genome editing; analytical laboratory services; medical laboratory services; scientific laboratory services; research laboratories; scientific research and development; development of pharmaceutical preparations and medicines; pharmaceutical products development; bioinformatic research for identification of target sequences for genome editing in a cell's DNA; bioinformatic research for identification of target sequences for genome editing in a cell's DNA by genome editable enzymes, DNA recombinant enzymes, dna editable enzymes, in particular recombinases and integrases; bioinformatic or computational analysis to identify target sequences in a cell's DNA; screening processes for the identification of genome editable enzymes, DNA recombinant enzymes, dna editable enzymes, in particular recombinases and integrases; research and development for the pharmaceutical industry; technological consultancy, relating to the following sectors: treatment of diseases by means of genome editable enzymes, dna recombinant enzymes, dna editable enzymes, in particular recombinases and integrases.
Mark Description:
N/A
Class:
Medical services
Type of Mark:
Trademark
Published for Opposition Date:
N/A
Owner:
Mark Drawing Status:
Design plus Words, Letters, and/or Numbers
Abandon Date:
N/A
Business Name:
N/A
Correspondent Name:
N/A
